{"transactions":[{"id":4634668,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-03T00:47:07.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":308,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25141,"source":{"system":"sec-edgar","filing":"0001655016-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000165501626000006/primarydocument.xml","form_type":"4"}},{"id":721250,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T23:46:25.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":319,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24833,"source":{"system":"sec-edgar","filing":"0001655016-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000165501626000004/primarydocument.xml","form_type":"4"}},{"id":736213,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T22:15:48.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":16377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 5, 2026 will become vested on the earlier of (i) June 5, 2027 or (ii) the business day prior to the 2027 annual meeting of stockholder."}],"balance_after":16377,"derivative":{"exercise_price":35.59,"exercise_date":"2027-06-02","expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":16377},"source":{"system":"sec-edgar","filing":"0001655016-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000165501626000003/primarydocument.xml","form_type":"4"}},{"id":816470,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T18:12:09.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":339,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24514,"source":{"system":"sec-edgar","filing":"0001655016-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000165501626000002/primarydocument.xml","form_type":"4"}},{"id":951617,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-05T22:33:21.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":473,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24175,"source":{"system":"sec-edgar","filing":"0001655016-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000165501626000001/primarydocument.xml","form_type":"4"}},{"id":1000283,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T23:04:59.000Z","date":"2025-11-11","kind":"purchase","planned":false,"acquired":true,"shares":10700,"price":18.6358,"value":199403.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $18.55 to $18.65, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":23702,"source":{"system":"sec-edgar","filing":"0001655016-25-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000165501625000007/primarydocument.xml","form_type":"4"}},{"id":1027366,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T00:29:26.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. (the \"Issuer\") common stock, granted and released to the reporting person on October 1, 2025, as a Quarterly Retainer Award pursuant to Section 2.4 of the Issuer's Outside Director Compensation Policy, as amended."}],"balance_after":13002,"source":{"system":"sec-edgar","filing":"0001655016-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000165501625000004/primarydocument.xml","form_type":"4"}},{"id":1095240,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T20:18:34.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. (the \"Issuer\") common stock, granted and released to the reporting person on July 1, 2025, as a Quarterly Retainer Award pursuant to Section 2.4 of the the Issuer's Outside Director Compensation Policy, as amended."}],"balance_after":12274,"source":{"system":"sec-edgar","filing":"0001562180-25-005233","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005233/primarydocument.xml","form_type":"4"}},{"id":1106349,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T23:36:55.000Z","date":"2025-06-16","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 16, 2025 will become vested on the earlier of (i) June 16, 2026 or (ii) the business day prior to the 2026 annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":14.68,"exercise_date":"2026-06-16","expiration_date":"2035-06-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-25-004959","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025004959/primarydocument.xml","form_type":"4"}},{"id":1179669,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T22:11:28.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted and released to the reporting person on April 1, 2025, as a Quarterly Retainer Award pursuant to Section 2.4 of the Edgewise Therapeutics, Inc. Outside Director Compensation Policy, as amended."}],"balance_after":11416,"source":{"system":"sec-edgar","filing":"0001562180-25-002992","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025002992/primarydocument.xml","form_type":"4"}},{"id":1482130,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T23:32:57.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":20594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 10, 2024 will become vested on the earlier of (i) June 10, 2025 or (ii) the business day prior to the 2025 annual meeting of stockholders."}],"balance_after":20594,"derivative":{"exercise_price":17.13,"exercise_date":"2025-06-10","expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":20594},"source":{"system":"sec-edgar","filing":"0001562180-24-005021","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024005021/primarydocument.xml","form_type":"4"}},{"id":1698642,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-28T21:39:30.000Z","date":"2023-12-26","kind":"purchase","planned":false,"acquired":true,"shares":10857,"price":9.2989,"value":100958.1573,"ownership":{"direct":true},"balance_after":10857,"source":{"system":"sec-edgar","filing":"0001562180-23-008573","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023008573/primarydocument.xml","form_type":"4"}},{"id":1855950,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-14T23:30:00.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":22123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 12, 2023 will become vested on the earlier of (i) June 12, 2024 or (ii) the business day prior to the date of the 2024 annual meeting of stockholders."}],"balance_after":22123,"derivative":{"exercise_price":9.55,"exercise_date":"2024-06-12","expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":22123},"source":{"system":"sec-edgar","filing":"0001562180-23-005178","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023005178/primarydocument.xml","form_type":"4"}},{"id":1965997,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-07T22:59:17.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":43731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest each month beginning on March 3, 2023, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":43731,"derivative":{"exercise_price":9.43,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":43731},"source":{"system":"sec-edgar","filing":"0001562180-23-002584","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023002584/primarydocument.xml","form_type":"4"}},{"id":2892223,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-28T19:50:50.000Z","date":"2021-01-26","kind":"disposition_to_issuer","acquired":false,"shares":70000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option vests over four years after November 5, 2018.  At the Effective Time, each such option was cancelled, assumed by Parent and replaced with an option to purchase 1.85 shares of Parent common stock at an exercise price per share of Parent common stock equal to the exercise price per share of the Issuer option divided by 1.85.  Such Parent stock option is subject to the same terms and conditions applicable to the Issuer option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over four years after November 5, 2018.  At the Effective Time, each such option was cancelled, assumed by Parent and replaced with an option to purchase 1.85 shares of Parent common stock at an exercise price per share of Parent common stock equal to the exercise price per share of the Issuer option divided by 1.85.  Such Parent stock option is subject to the same terms and conditions applicable to the Issuer option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":13.2,"expiration_date":"2028-11-05","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000899243-21-003671","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924321003671/doc4.xml","form_type":"4"}},{"id":2892222,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-28T19:50:50.000Z","date":"2021-01-26","kind":"other","acquired":false,"shares":380467,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger dated October 5, 2020 (the \"Merger Agreement\"), by and among the Issuer, BridgeBio Pharma, Inc. (\"Parent\"), Globe Merger Sub 1, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), and Globe Merger Sub II, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub II\"), Merger Sub was merged with and into the Issuer, with the Issuer continuing as the surviving corporation and immediately thereafter, the Issuer was merged with and into Merger Sub II, with Merger Sub II continuing as the surviving corporation, effective as of January 26, 2021 (the \"Effective Time\"). At the Effective Time, each share of Issuer common stock that was outstanding and held by the Reporting Person immediately prior to the Effective Time was cancelled and automatically converted into 1.85 shares of Parent common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger dated October 5, 2020 (the \"Merger Agreement\"), by and among the Issuer, BridgeBio Pharma, Inc. (\"Parent\"), Globe Merger Sub 1, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), and Globe Merger Sub II, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub II\"), Merger Sub was merged with and into the Issuer, with the Issuer continuing as the surviving corporation and immediately thereafter, the Issuer was merged with and into Merger Sub II, with Merger Sub II continuing as the surviving corporation, effective as of January 26, 2021 (the \"Effective Time\"). At the Effective Time, each share of Issuer common stock that was outstanding and held by the Reporting Person immediately prior to the Effective Time was cancelled and automatically converted into 1.85 shares of Parent common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-003671","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924321003671/doc4.xml","form_type":"4"}},{"id":2892221,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-28T19:50:50.000Z","date":"2020-12-28","kind":"gift","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":380467,"source":{"system":"sec-edgar","filing":"0000899243-21-003671","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924321003671/doc4.xml","form_type":"4"}},{"id":3027092,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-09-18T16:06:08.000Z","date":"2020-09-17","kind":"sale","acquired":false,"shares":5767,"price":50.1576,"value":289258.8792,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $50.00 to $50.46 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":377673,"source":{"system":"sec-edgar","filing":"0000899243-20-025694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320025694/doc4.xml","form_type":"4"}},{"id":3030371,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-09-16T18:35:12.000Z","date":"2020-09-16","kind":"sale","acquired":false,"shares":3122,"price":50.1632,"value":156609.5104,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $50.015 to $50.36 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":383440,"source":{"system":"sec-edgar","filing":"0000899243-20-025364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320025364/doc4.xml","form_type":"4"}},{"id":3030370,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-09-16T18:35:12.000Z","date":"2020-09-15","kind":"sale","acquired":false,"shares":1000,"price":50.064,"value":50064.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $50.00 to $50.11 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":386562,"source":{"system":"sec-edgar","filing":"0000899243-20-025364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320025364/doc4.xml","form_type":"4"}},{"id":3030369,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-09-16T18:35:12.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":111,"price":50,"value":5550.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":387562,"source":{"system":"sec-edgar","filing":"0000899243-20-025364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320025364/doc4.xml","form_type":"4"}},{"id":3085723,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-07-09T16:05:26.000Z","date":"2020-07-07","kind":"sale","acquired":false,"shares":5000,"price":50,"value":250000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":387673,"source":{"system":"sec-edgar","filing":"0000899243-20-018813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320018813/doc4.xml","form_type":"4"}},{"id":3095400,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-07-01T16:06:07.000Z","date":"2020-06-29","kind":"other","acquired":true,"shares":1088,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 4, 2020, the Reporting Person gifted 1,088 shares in a private transaction. The gift was rescinded on June 29, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":392673,"source":{"system":"sec-edgar","filing":"0000899243-20-018110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320018110/doc4.xml","form_type":"4"}},{"id":3120630,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-06-05T16:06:03.000Z","date":"2020-06-03","kind":"sale","acquired":false,"shares":5000,"price":50,"value":250000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":391585,"source":{"system":"sec-edgar","filing":"0000899243-20-015413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320015413/doc4.xml","form_type":"4"}},{"id":3120629,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-06-05T16:06:03.000Z","date":"2020-06-02","kind":"gift","acquired":false,"shares":1020,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":396585,"source":{"system":"sec-edgar","filing":"0000899243-20-015413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320015413/doc4.xml","form_type":"4"}},{"id":3120628,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-06-05T16:06:03.000Z","date":"2020-06-01","kind":"gift","acquired":false,"shares":1020,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":397605,"source":{"system":"sec-edgar","filing":"0000899243-20-015413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320015413/doc4.xml","form_type":"4"}},{"id":3120627,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-06-05T16:06:03.000Z","date":"2020-05-31","kind":"grant","acquired":true,"shares":444,"price":41.5735,"value":18458.634,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to the Issuer's 2018 Employee Stock Purchase Plan."}],"balance_after":3294,"source":{"system":"sec-edgar","filing":"0000899243-20-015413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320015413/doc4.xml","form_type":"4"}},{"id":3129192,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-06-01T16:05:19.000Z","date":"2020-05-28","kind":"sale","acquired":false,"shares":5000,"price":50,"value":250000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":398625,"source":{"system":"sec-edgar","filing":"0000899243-20-014714","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320014714/doc4.xml","form_type":"4"}},{"id":3169109,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-27T16:05:49.000Z","date":"2020-04-24","kind":"sale","acquired":false,"shares":2153,"price":50,"value":107650.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":403625,"source":{"system":"sec-edgar","filing":"0000899243-20-011341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320011341/doc4.xml","form_type":"4"}},{"id":3169108,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-27T16:05:49.000Z","date":"2020-04-23","kind":"sale","acquired":false,"shares":2847,"price":50,"value":142350.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":405778,"source":{"system":"sec-edgar","filing":"0000899243-20-011341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320011341/doc4.xml","form_type":"4"}},{"id":3227858,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-03-04T16:05:39.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":10000,"price":51.5706,"value":515706.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold from $51.50 to $52.05 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":408625,"source":{"system":"sec-edgar","filing":"0000899243-20-006941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320006941/doc4.xml","form_type":"4"}},{"id":3263687,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-19T06:05:18.000Z","date":"2020-02-13","kind":"sale","acquired":false,"shares":10000,"price":54,"value":540000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":418625,"source":{"system":"sec-edgar","filing":"0000899243-20-005000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320005000/doc4.xml","form_type":"4"}},{"id":3263686,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-19T06:05:18.000Z","date":"2020-02-04","kind":"gift","acquired":false,"shares":1632,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":428625,"source":{"system":"sec-edgar","filing":"0000899243-20-005000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320005000/doc4.xml","form_type":"4"}},{"id":3309755,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-01-16T18:35:41.000Z","date":"2020-01-15","kind":"sale","acquired":false,"shares":3580,"price":55,"value":196900.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":430257,"source":{"system":"sec-edgar","filing":"0000899243-20-001337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320001337/doc4.xml","form_type":"4"}},{"id":3309754,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-01-16T18:35:41.000Z","date":"2020-01-14","kind":"sale","acquired":false,"shares":6420,"price":55.0112,"value":353171.904,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares ranging from $50.00 to $55.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":433837,"source":{"system":"sec-edgar","filing":"0000899243-20-001337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320001337/doc4.xml","form_type":"4"}},{"id":3314570,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-01-09T18:53:37.000Z","date":"2019-12-30","kind":"gift","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":440257,"source":{"system":"sec-edgar","filing":"0000899243-20-000901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320000901/doc4.xml","form_type":"4"}},{"id":3314569,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-01-09T18:53:37.000Z","date":"2019-12-26","kind":"gift","acquired":false,"shares":170,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":440357,"source":{"system":"sec-edgar","filing":"0000899243-20-000901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320000901/doc4.xml","form_type":"4"}},{"id":3351074,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-12-05T19:31:18.000Z","date":"2019-12-04","kind":"sale","acquired":false,"shares":10000,"price":58.9048,"value":589048.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold ranging from $58.83 to $59.41 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":440527,"source":{"system":"sec-edgar","filing":"0000899243-19-028617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028617/doc4.xml","form_type":"4"}},{"id":3351073,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-12-05T19:31:18.000Z","date":"2019-11-26","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":450527,"source":{"system":"sec-edgar","filing":"0000899243-19-028617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028617/doc4.xml","form_type":"4"}},{"id":3357716,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-11-27T21:00:21.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":10000,"price":56.5218,"value":565218.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold ranging from $56.25 to $57.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":451527,"source":{"system":"sec-edgar","filing":"0000899243-19-028274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028274/doc4.xml","form_type":"4"}},{"id":3361297,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-11-22T21:00:25.000Z","date":"2019-11-21","kind":"sale","acquired":false,"shares":10000,"price":55.1073,"value":551073.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold ranging from $55.01 to $55.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":461527,"source":{"system":"sec-edgar","filing":"0000899243-19-028028","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028028/doc4.xml","form_type":"4"}},{"id":3366126,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-11-19T16:05:35.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":10000,"price":50.2574,"value":502574.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of the shares ranging from $50.00 to $50.36 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":471527,"source":{"system":"sec-edgar","filing":"0000899243-19-027574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319027574/doc4.xml","form_type":"4"}},{"id":3366125,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-11-19T16:05:35.000Z","date":"2019-11-15","kind":"sale","acquired":false,"shares":900,"price":46.45,"value":41805.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares ranging from $46.39 to $46.48 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":481527,"source":{"system":"sec-edgar","filing":"0000899243-19-027574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319027574/doc4.xml","form_type":"4"}},{"id":3366124,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-11-19T16:05:35.000Z","date":"2019-11-15","kind":"sale","acquired":false,"shares":2100,"price":45.5082,"value":95567.22,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares ranging from $45.24 to $46.02 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":482427,"source":{"system":"sec-edgar","filing":"0000899243-19-027574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319027574/doc4.xml","form_type":"4"}},{"id":3366123,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-11-19T16:05:35.000Z","date":"2019-11-15","kind":"sale","acquired":false,"shares":2000,"price":44.8786,"value":89757.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares ranging from $44.23 to $45.16 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":484527,"source":{"system":"sec-edgar","filing":"0000899243-19-027574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319027574/doc4.xml","form_type":"4"}},{"id":3392945,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-10-16T16:58:27.000Z","date":"2019-10-15","kind":"sale","acquired":false,"shares":2,"price":36.71,"value":73.42,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":486527,"source":{"system":"sec-edgar","filing":"0000899243-19-025615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319025615/doc4.xml","form_type":"4"}},{"id":3392944,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-10-16T16:58:27.000Z","date":"2019-10-15","kind":"sale","acquired":false,"shares":4998,"price":36.1633,"value":180744.1734,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares ranging from $35.71 to $36.69 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":486529,"source":{"system":"sec-edgar","filing":"0000899243-19-025615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319025615/doc4.xml","form_type":"4"}},{"id":3410991,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-09-18T16:05:36.000Z","date":"2019-09-16","kind":"sale","acquired":false,"shares":5000,"price":45.7444,"value":228722.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares ranging from $45.14 to $46.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":491527,"source":{"system":"sec-edgar","filing":"0000899243-19-023815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319023815/doc4.xml","form_type":"4"}},{"id":3434647,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-08-19T19:18:45.000Z","date":"2019-08-15","kind":"sale","acquired":false,"shares":2780,"price":39.0091,"value":108445.298,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares ranging from $38.72 to $39.42 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":496527,"source":{"system":"sec-edgar","filing":"0000899243-19-022075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319022075/doc4.xml","form_type":"4"}},{"id":3434646,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-08-19T19:18:45.000Z","date":"2019-08-15","kind":"sale","acquired":false,"shares":2220,"price":38.3561,"value":85150.542,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares ranging from $37.71 to $38.70 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":499307,"source":{"system":"sec-edgar","filing":"0000899243-19-022075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319022075/doc4.xml","form_type":"4"}},{"id":3460065,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-07-17T16:05:41.000Z","date":"2019-07-15","kind":"sale","acquired":false,"shares":15000,"price":40.0374,"value":600561.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares ranging from $39.67 to $40.59 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":501527,"source":{"system":"sec-edgar","filing":"0000899243-19-019765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319019765/doc4.xml","form_type":"4"}},{"id":3460064,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-07-17T16:05:41.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":1769,"price":12.0105,"value":21246.5745,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to the Issuer's 2018 Employee Stock Purchase Plan."}],"balance_after":2850,"source":{"system":"sec-edgar","filing":"0000899243-19-019765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319019765/doc4.xml","form_type":"4"}},{"id":3506472,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-05-31T16:17:53.000Z","date":"2019-05-30","kind":"sale","acquired":false,"shares":5000,"price":32.6357,"value":163178.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold ranging from $32.63 to $32.68 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":516527,"source":{"system":"sec-edgar","filing":"0000899243-19-015285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319015285/doc4.xml","form_type":"4"}},{"id":3538218,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-05-06T20:37:00.000Z","date":"2019-05-03","kind":"sale","acquired":false,"shares":5000,"price":25.03,"value":125150.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold ranging from $25.02 to $25.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":521527,"source":{"system":"sec-edgar","filing":"0000899243-19-012357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319012357/doc4.xml","form_type":"4"}},{"id":3540101,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-05-03T21:52:14.000Z","date":"2019-05-01","kind":"sale","acquired":false,"shares":3892,"price":25.3,"value":98467.6,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":526527,"source":{"system":"sec-edgar","filing":"0000899243-19-012105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319012105/doc4.xml","form_type":"4"}},{"id":3540100,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-05-03T21:52:14.000Z","date":"2019-05-01","kind":"sale","acquired":false,"shares":1108,"price":26.01,"value":28819.08,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Jonathan C Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":530419,"source":{"system":"sec-edgar","filing":"0000899243-19-012105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319012105/doc4.xml","form_type":"4"}},{"id":3540099,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-05-03T21:52:14.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":1081,"price":12.01,"value":12982.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to the Issuer's 2018 Employee Stock Purchase Plan."}],"balance_after":1081,"source":{"system":"sec-edgar","filing":"0000899243-19-012105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319012105/doc4.xml","form_type":"4"}},{"id":3555083,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-04-16T21:10:22.000Z","date":"2019-04-15","kind":"sale","acquired":false,"shares":5000,"price":23.11,"value":115550.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held by Jonathan C Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014."}],"balance_after":531527,"source":{"system":"sec-edgar","filing":"0000899243-19-010707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319010707/doc4.xml","form_type":"4"}},{"id":3771604,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":34000,"kind":"person","name":"Fox Jonathan C","position":1,"cik":"0001655016","reported_name":"Fox Jonathan C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2018-11-07T19:08:48.000Z","date":"2018-11-05","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person is a participant in the Issuer's 2018 Stock Option and Incentive Plan and received 70,000 stock options (the \"Grant\") on November 5, 2018.  The shares subject to the Grant shall vest as follows: one quarter of the shares shall vest on November 5, 2019 and the remaining unvested shares shall vest ratably over the following 36 months, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":70000,"derivative":{"exercise_price":13.2,"expiration_date":"2028-11-05","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000899243-18-028484","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924318028484/doc4.xml","form_type":"4"}}]}